Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trialHarry P. Erba, Richard F. Schlenk, Radovan Vrḫovac et al.|The Lancet|2023Cited by 387
Chromosomal Abnormalities and Prognosis in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International CohortsLinus Angenendt, Christoph Schliemann, Christoph Röllig et al.|Journal of Clinical Oncology|2019Cited by 116